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Background: China is implementing a National Malaria Elimination Programme. A high proportion of clinically
diagnosed malaria cases is reported in some provinces of China. In order to understand the exact situation and
make clear the nature of these patients, it is of much importance to make case verifications, particularly from the
pathogenic perspective.
Methods: Guizhou Province was targeted because of its high proportion of clinically diagnosed malaria cases. After
random selection of around 10% of malaria cases from 1 May 2011 to 30 April 2012, reported through the national
web-based case reporting system from this province, field verifications were made on 14–17 May 2012 as follows.
Firstly, the reported information of each case was rechecked with the onsite case registrations and investigation
forms, and an in-depth interview was conducted with each patient. Secondly, the patient’s blood smears kept by
local CDC were cross-checked microscopically by a national experienced microscopist. Thirdly, two kinds of
polymerase chain reaction (PCRs). including Tag-primer nested/multiplex PCR (UT-PCR) based on cytochrome
oxidase gene (cox I) and nested PCR based on 18s rRNA gene were performed simultaneously using local CDC kept
filter paper of dry blood samples to identify the Plasmodium spp.
Results: Twelve out of 152 malaria cases were selected, including nine clinically diagnosed malaria cases, two
confirmed falciparum malaria cases and one confirmed vivax malaria case. The original case documents on the site
were completely in conformity with their reported data, and all the patients recalled their malaria symptoms and
being cured only after consuming the corresponding anti-malarial drugs. Moreover, the re-examination results of
microscopy and PCR were exactly in agreement with the original tests.
Discussion: No inconsistent results were found against the reported case information in the present study and the
reasons for clinically diagnosed patients remains unclear. Uniform and standardized sample collection and
processing should be trained among clinicians, more sensitive and specific techniques should be explored to used
in malaria diagnosis. A further study is needed in order to be more observationally focussed rather than
retrospective.
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As the lowest malaria burden was achieved, in order
to protect the public health and respond to global
malaria elimination initiative, the Chinese government
launched the Action Plan of China Malaria Elimination
(2010–2020) [1] in 2010 with an overall goal:- by 2015,
local transmission of malaria should be eliminated except
for partial border areas in Yunnan Province; and by 2020,
malaria elimination should be achieved nationwide. In
2011, the malaria cases reported was reduced about 43.0%
compared 2010, and accordingly the annual incidence was
reduced to 0.0334/10,000. Furthermore, there were 56.7%
vivax malaria and 40.2% falciparum malaria among the
cases with laboratory confirmation [2].
The definition of malaria case in an elimination pro-
gramme is very different from a control programme. In
an elimination programme, it is defined as a person
in whom, regardless of the presence or absence of clin-
ical symptoms, malaria parasites have been confirmed by
quality controlled laboratory diagnosis [3,4]. In the Ac-
tion Plan of China Malaria Elimination (2010–2020) [1]
as well as the Technical Scheme of China Malaria Eli-
mination (2011 Edition) [5], it is the requirement that by
2012 the laboratory testing rate of malaria cases should
reach 100% and the rate of laboratory confirmation
should reach 75%. However, a number of clinically diag-
nosed or unconfirmed cases still exists. According to the
national web-based case reporting system, it was noted
that the proportion of clinically diagnosed malaria cases
were over 25% in about one-third (10/34); Provinces/
Municipalities/Autonomous Regions in China; and al-
most reached 90% in the key malaria-prevalent Province
of Guizhou.
As every one of the malaria patients should be labora-
tory confirmed during elimination stage, it is necessary
to make case verifications, particularly from the pa-
thogenic perspective in order to understand the exact
situation and make clear the nature of these clinically
diagnosed patients.Methods
Sample enrolment
Using the national web-based case reporting system,
around 10% malaria cases reported from Guizhou
Province during 1 May 2011 to 30 April 2012 were
randomly selected into the present study, since the
verifications were planned on 14–17 May 2012. All
the reported case cards that had patients’ basic and
diagnostic data were downloaded. All the original case
registrations and investigation forms were from on
site; and for each case, one slide of blood smears and
one filter paper of dried blood spots kept in Guizhou
provincial CDC were obtained.Case document review and case interview
All the reported information, including the name, gen-
der, age, residence, date of fever onset, date and result of
diagnosis, responsible health facility and doctor, etc., were
compared manually with the original documents for
each targeted patient. Afterwards, household interview
with each patient was done in order to verify their exis-
tence, as reported.
Ethical clearance
The study was reviewed and approved by the Ethical
Committee of National Institute of Parasitic Diseases,
China CDC. All patients provided informed consent be-
fore admission into the study.
Microscopy
Both thin and thick blood smears of each Giemsa-stained
slide were qualitatively evaluated and checked for malaria
species by an assigned experienced microscopist from
NIPD, China CDC, who was blinded to the results. The
examination was performed following the WHO standard
protocol under a 100× oil immersion objective [6].
DNA extraction and PCR amplification
In Guizhou provincial CDC, two different methods for
DNA extraction and polymerase chain reaction (PCR) am-
plification were applied simultaneously by two indepen-
dent technicians: one from NIPD and one from Guizhou
provincial CDC.
For the technician from Guizhou provincial CDC, a
piece of 6 mm diameter dry blood sample containing
around 4 μl whole blood was put into a 0.5 ml EP tube,
then 400 μl PCR buffer (1×) was added, and centrifuged
at 18,000×g for 2 min after 10 min standing at room
temperature, then 20 μl PCR buffer (1×) added again af-
ter suspension discarded, and heated at 95°C for 5 min,
centrifuged at 18,000×g for 1 min, and the suspension
was the template stored at 4°C until use; a method of
Tag-primer nested/multiplex PCR (UT-PCR) which can
detect one parasite/μl was applied, the target gene was
the cytochrome oxidase gene (cox I) which is located in
mitochondrion, and seven primers were designed for
this amplification [7].
However, for the technician from NIPD, DNA was
extracted from dry blood sample using the QIAamp
DNA Mini Kit (Qiagen), in accordance with the manufac-
turer’s instruction. Qualitative detection of Plasmodium
spp. through nested PCR amplification based on multi-
copy 18s rRNA gene in a reaction of 20 μl as described
elsewhere [8] with some minor adjustments. Moreover,
two positive controls consisting of Plasmodium vivax
DNA and Plasmodium falciparum DNA separately, and
a negative control consisting of DNA extracted from
malaria-negative blood and a blank control consisting of
Figure 1 The target province and selected samples’ distribution.
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addition, amplified regions were separated using 2% aga-
rose gel electrophoresis and visualized following GelRed
staining.
Results
Target province and selected samples
Guizhou Province was targeted because of its high pro-
portion of clinically diagnosed malaria cases. From 1
May 2011 to 30 April 2012, 86.18% (131/152) repor-
ted malaria cases from this province were diagnosedTable 1 Basic data and verification results of the study sampl
Code Gender Age (y) Onset time
M2 Male 55 June 2011
M3 Male 48 August 2011
SD1 Male 69 May 2011
SD2 Male 55 June 2011
SD6 Male 16 August 2011
SD8 Male 10 August 2011
SD11 Female 25 August 2011
SD19 Male 38 September 2011
LD5 Male 53 July 2011
LD12 Male 65 August 2011
CJ3 Female 36 July 2011
CH5 Female 35 April 2011
* M2 attacked only one day after his return from Nigeria;
M3 attacked a week after his return from Benin.as “clinical cases” according to the clinical symptoms
related to malaria despite negative results of labora-
tory test through microscopy.
Twelve out of 152 malaria cases were selected into
the present study. Two confirmed imported falciparum
malaria cases were from Guiyang City (code: M2, M3);
nine clinically diagnosed local malaria cases were from
Sandu County (code: SD1, SD2, SD6, SD8, SD11, SD19),
Luodian County (code: LD5, LD12) and Ceheng County
(code: CH5); and one confirmed local vivax malaria case
from Congjiang County (code: CJ3) (Figure 1 and Table 1).es
Original diagnosis Plasmodium spp. verified
Imported falciparum malaria* P. falciparum
Imported falciparum malaria* P. falciparum
Local clinical case Negative
Local clinical case Negative
Local clinical case Negative
Local clinical case Negative
Local clinical case Negative
Local clinical case Negative
Local clinical case Negative
Local clinical case Negative
Local vivax malaria P. vivax
Local clinical case Negative
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The original case documents on the site were completely
in conformity with their reported data, and all the pa-
tients recalled their malaria symptoms and being cured
only after consuming the corresponding anti-malarial
drugs according to national guidelines [9].
Moreover, the re-examination results of microscopy
and PCRs were in agreement with the original tests. The
results of slides were identical to each other, tested by
two different microscopists from Guizhou provincial
CDC and NIPD respectively. Besides, the result of gel
electrophoresis showed that cox I and18s rRNA genes
were successfully amplified as a result of P. falciparum
with the band around 200 bp (18s rRNA) and 620 bp
(cox I) from two Guiyang City samples and the P. falcip-
arum positive control by two methods mentioned above
separately; and one sample from Congjiang County and the
P. vivax positive control was detected as P. vivax around
120 bp (18s rRNA) and 220 bp (cox I) based on these two
target genes; all the rest of the samples were negative.
Discussion
Malaria has been a major public health problem histori-
cally in China, and China has made an impact on mala-
ria disease burden with successful large-scale malaria
control activities nationwide [10,11] and is now entering
an age of malaria elimination since the Action Plan of
China Malaria Elimination (2010–2020) was presented.
In recent years, the number of malaria cases in China
has been declining, with a yearly average of 46.09% [12];
most areas are free of endemic malaria, and some are
in the low prevalence, this includes Guizhou, a western
province bordering with Yunnan, Sichuan, Chongqing,
Guangxi and Hunan Provinces/Municipalities/Autonomous
Regions [13].
Generally in low transmission areas, due to the exist-
ence of asymptomatic and low parasitaemia malaria pa-
tients, prompt and effective detection/diagnosis has been
a problem. Although light microscopy can characterize
and quantify Plasmodium parasites rapidly and is the
operational gold standard in control and elimination set-
tings [14,15], the asymptomatic and micro-parasitaemia
infections are beyond its detective capability [16-18]. As
a result, PCR has got to be recognized as the reliable
and sensitive method for malaria diagnosis, particularly
to detect the submicroscopy Plasmodium infection, and
it can identify morphologically similar species [19-21].
The methods of detecting circulating parasites by de-
monstrating parasite DNA through PCR assays based on
18s rRNA gene represent the overall gold standard of
malaria diagnostics [22].
However in Guizhou Province, the problem is not just
the asymptomatic and low-parasitaemia infection under
low malaria transmission, but also that most malaria caseswere reported having clinical malaria symptoms and sus-
ceptible to the anti-malarial drugs, but with no laboratory
evidence of Plasmodium infection. In view of uncertainty
in the real malaria burden of Guizhou Province, this study
using retrospective design and comprehensive crosscheck
approaches of case document review, case interview, mi-
croscopy and the more sensitive PCRs, attempted to
understand the real malaria infections including both the
asymptomatic and symptomatic, and tried to identify the
differences between the results by light microscopy and
PCR in such a context.
In this study, in order to ensure the accuracy of patho-
genic confirmation, besides light microscopy, two kinds
of PCR were used. One is nested PCR based on 18s
rRNA gene, and the other is Tag-primer nested/multi-
plex PCR (UT-PCR) based on cytochrome oxidase gene
(cox I). Nested PCR based on 18s rRNA gene [8] has
been widely used in laboratories, clinics and field [23,24]
for Plasmodium characterization; it demonstrated that
this method was much more efficient although there are
limitations. UT-PCR based on cox I gene in this study
showed both sensitivity and specificity were higher than
98% [7], and the detection limit of either P. falciparum or
P. vivax reached one parasite/μl [25]. Thus, random sam-
pling, case document review, case interview, blood sam-
ples recheck or crosscheck through two PCRs combined
with two experienced microscopists, were much more
powerful for malaria detection/diagnosis theoretically.
In the present study, all the results from different
methods were in good agreement with each other, and
no inconsistent results were found against the reported
cases information; however, the reason for clinically di-
agnosed patients remains unclear. It may be attributed
to incorrect sampling or the clinically diagnosed patients
infected with other pathogen rather than Plasmodium
with symptoms similar to malaria, which were also sus-
ceptible to anti-malarial drugs. Although malaria diagno-
sis reference laboratory network has started in China
since 2011, and several provincial reference laboratories
have been set up in provincial CDC, respectively, it was
suggested that clinicians should be trained for uniform
and standardized sample collection and processing. Fur-
thermore, it is recommended that more sensitive and
specific techniques be used in malaria diagnosis, but no
inconsistent results were found in this study.
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